Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions novel findings in research to molecular aspects of all types of human cancers. This section ranges from basic sciences to preclinical research. We encourage submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. We also encourage submission of high-quality manuscripts that focus on translating basic molecular knowledge to new clinical applications in oncology. The scope of this section includes, but is not limited to, the following:
- Biological processes, like gene activity in relation with specific molecular pathways, in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular interactions in the tumor microenvironment, including tumor-immune interactions
- Genomic profiling of human cancers and any other ‘systems biology’ approaches in understanding development of human cancers
- Preclinical research that leads to novel therapies derived from molecular processes and cellular interactions, including gene therapy, therapy based on biologicals, hormonal therapy, and cancer vaccines and other types of immunotherapies
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Precision Cancer Medicine: Molecular Insights, Biological Events and Clinical Perspectives (Deadline: 20 June 2026)
- DNA Damage Response from Molecular Mechanisms to Cancer Therapy (Deadline: 20 June 2026)
- Obesity and Cancer Risk: Molecular Mechanisms and Perspectives (Deadline: 20 June 2026)
- Deciphering Molecular Complexity of Pancreatic Cancer (Deadline: 20 June 2026)
- Cutting-Edge Advances in New Anticancer Agents: Design, Synthesis and Application (Deadline: 20 June 2026)
- Urothelial Cancer: From Translational Medicine to Recent Innovations in Therapeutic Management (Deadline: 20 June 2026)
- MicroRNA (miRNA) Technology in Cancer (Deadline: 20 June 2026)
- Targeting Glioblastoma Metabolism (Deadline: 20 June 2026)
- Ovarian Cancer: Pathogenesis, Biomarkers and Treatment (Deadline: 20 June 2026)
- Innovations in Photodynamic Therapy: New Horizons in Breast Cancer Care (Deadline: 20 June 2026)
- Advances in Ovarian Cancer Metastasis and Chemotherapy Resistance (Deadline: 20 June 2026)
- Colorectal Cancer: Molecular and Cellular Basis (Deadline: 20 June 2026)
- Biology of Oral Cancer (Deadline: 20 June 2026)
- Skin Cancer: From Molecular Pathophysiology to Novel Treatment (Deadline: 20 June 2026)
- Regulation and Targeting of Ferroptosis in Tumor and Beyond (Second Edition) (Deadline: 20 June 2026)
- Role of Immune Cells in Cancers (Deadline: 20 June 2026)
- Cancer Biology: From Genetic Aspects to Treatment, 2nd Edition (Deadline: 20 June 2026)
- Molecular Research in Hematologic Malignancies (Deadline: 20 June 2026)
- Neuroendocrine Tumors: From Molecular Pathology to Novel Therapeutic Approaches, Including Theranostics (Deadline: 20 June 2026)
- Cancer-Associated Stromal Cells (Deadline: 20 June 2026)
- Combined and Mixture Exposure Toxicology of Cancer and Chronic Diseases (Deadline: 20 June 2026)
- Oncogenes and Tumor Suppressors: From Basic Science to Therapeutic Applications (Deadline: 20 June 2026)
- Pathogenesis and Molecular Therapy of Brain Tumor (Deadline: 20 June 2026)
- Recent Advances in Molecular Research and Therapeutic Strategies for Endometrial Cancer (Deadline: 20 June 2026)
- Multifaceted Roles of Extracellular Vesicles in Cancer and Other Diseases (Deadline: 20 June 2026)
- Molecular Aspects of Tumor Radiotherapy (Deadline: 20 June 2026)
- T-Cell Lymphoma: From Basic Science to Novel Therapeutics (Deadline: 20 June 2026)
- Exploring Molecular Mechanisms of Prostate Cancer (Deadline: 20 June 2026)
- Epigenetic Alterations in Hepatocellular Carcinoma (Deadline: 20 June 2026)
- Advances in Targeted Therapy and Immunotherapy for Lung Cancer (Deadline: 20 June 2026)
- Emerging Strategies Targeting Solid Tumors and the Tumor Microenvironment (Deadline: 20 June 2026)
- Hepatocellular Carcinoma: From Pathophysiology to Innovative Therapeutic Approaches (Deadline: 20 June 2026)
- Molecular Mechanisms and Therapies of Pancreatic Cancer: 3rd Edition (Deadline: 20 June 2026)
- Molecular Regulatory Mechanisms of the Tumor Microenvironment in Human Diseases (Deadline: 20 June 2026)
- Melanoma: Molecular Mechanism and Therapy, 2nd Edition (Deadline: 25 June 2026)
- Glycosylation in Tumor Microenvironment: Roles, Mechanisms and Interventions (Deadline: 25 June 2026)
- Cancer Stem Cells: Molecular Mechanisms and Therapeutic Targeting (Deadline: 25 June 2026)
- Current Research on Cancer Biology and Therapeutics: Fourth Edition (Deadline: 29 June 2026)
- Non-small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 June 2026)
- Wnt/β-Catenin Signaling in Cancer (Deadline: 30 June 2026)
- Hormone Receptor in Breast Cancer: 2nd Edition (Deadline: 30 June 2026)
- Molecular Mechanism and Therapeutics in Human Cancer (Deadline: 30 June 2026)
- Leukemia in the Omics Era: From Mechanisms to Therapies (Deadline: 30 June 2026)
- Advances in Multi-Omics in Cancer: Second Edition (Deadline: 30 June 2026)
- Breast Cancer: From Pathophysiology to Novel Therapies, 2nd Edition (Deadline: 30 June 2026)
- Exploring Molecular Mechanisms Involved in Head and Neck Cancer (Deadline: 30 June 2026)
- Metabolic Features of Breast Cancer: From Understanding Heterogeneous Biology to Developing New Therapies (Deadline: 30 June 2026)
- Cancer Drugs That Target Epigenetic Processes (Deadline: 30 June 2026)
- Molecular Advances in Cancer and Cell Metabolism—3rd Edition (Deadline: 30 June 2026)
- Molecular Determinants of Therapeutic Response and Resistance in Urological Cancers (Deadline: 30 June 2026)
- Breast Cancer: From Molecular Mechanism to Therapeutic Strategy (Deadline: 10 July 2026)
- Cancer Immunotherapy on Checkpoint Inhibitors: Future Directions (Deadline: 10 July 2026)
- Insights into the Pathogenesis, Molecular Landscape and Therapeutics of Triple-Negative Breast Cancer (Deadline: 20 July 2026)
- Genomic Research in Carcinogenesis, Cancer Progression and Recurrence (Deadline: 20 July 2026)
- Biological Hallmarks and Therapeutic Strategies in Cancer (Deadline: 20 July 2026)
- Precision Medicine in Cancers (Deadline: 20 July 2026)
- Innovative Research on Nutrition and Epigenetics in Cancer (Deadline: 20 July 2026)
- Molecular Insights into Environmental Toxicology in Cancer (Deadline: 20 July 2026)
- Unraveling the Enigma of Colorectal Cancer: From Mechanisms to Therapeutic Advances (Deadline: 20 July 2026)
- Molecular Diagnosis and Treatment of Colorectal Cancer (Deadline: 20 July 2026)
- Molecular Insights into Hepatocellular Carcinoma: From Carcinogenesis to Liver Transplantation (Deadline: 20 July 2026)
- Circulating Tumor Cells in Oncology: From Liquid Biopsy to Clinical Decision-Making (Deadline: 20 July 2026)
- Molecular Insights into Glioblastoma Pathogenesis and Therapeutics (Deadline: 20 July 2026)
- Innovative Strategies in Cancer Therapy (Deadline: 20 July 2026)
- Pathogenesis and Treatments of Head and Neck Cancer: 2nd Edition (Deadline: 20 July 2026)
- Skin Cancer: A Focus from Pathophysiology to Novel Therapeutic Strategies (Deadline: 20 July 2026)
- Adhesion, Invasion, and Metastasis in Cancer Progression (Deadline: 20 July 2026)
- Characterization of Immune and Inflammatory Tumor Microenvironment on Canine, Feline and Human Species (Deadline: 20 July 2026)
- Recent Advances in Molecular Mechanisms of Human Papillomavirus Family (HPV) Induced Oncogenesis, 2nd Edition (Deadline: 20 July 2026)
- Recent Advances in Gastrointestinal Cancer, 3rd Edition (Deadline: 20 July 2026)
- Phytochemicals in Cancer Therapy: From Preclinical Studies to Clinical Practice (Deadline: 20 July 2026)
- Recent Advances in Anti-Cancer Drugs, 2nd Edition (Deadline: 30 July 2026)
- Molecular Advances in Gynecologic Cancer, 2nd Edition (Deadline: 30 July 2026)
- Cancer Drug Resistance and Therapeutic Targets (Deadline: 30 July 2026)
- New Molecular Insights into Myeloma (Deadline: 30 July 2026)
- Molecular Mechanisms and Therapies of Gastrointestinal Cancer (Deadline: 31 July 2026)
- Recent Advances in 3D Tumor Models for Cancer Research (Deadline: 31 July 2026)
- Radiolabeled Compounds for Theranostic Applications in Oncology (Deadline: 31 July 2026)
- Study on the Microenvironment in Lymphoma (Deadline: 31 July 2026)
- The Impact of the Immune System on the Tumor Microenvironment: Relevance to Glioma Development (Deadline: 31 July 2026)
- Molecular Dialogues in the Tumor Microenvironment: Mechanisms, Methods and Therapeutic Implications (Deadline: 31 July 2026)
- Targeting Hallmarks of Acute Myelocytic Leukemia (AML): Differentiation Induction in Non-Acute Promyelocytic Leukemia (Non-APL) AML (Deadline: 31 July 2026)
- Aptamers in Cancer Therapy: Mechanisms, Applications, and Translational Perspectives (Deadline: 31 July 2026)
- Anticancer Drugs: Molecular Research and Progress (Deadline: 31 July 2026)
- Molecular Mechanisms and Treatments of Prostate Cancer (Deadline: 31 July 2026)
- Molecular Mechanisms and Therapeutic Strategies in Gastrointestinal Cancer (Deadline: 31 July 2026)
- Molecular Disruption Strategies for Enhancing Tumor Radiosensitization (Deadline: 31 July 2026)
- Genetic-Driven Precision Oncology in Prostate Cancer (Deadline: 31 July 2026)
- Cancer Genomics and Immunotherapy: Mechanisms, Biomarkers, and Clinical Translation (Deadline: 31 July 2026)
- Proteoglycans and Glycosaminoglycans in Cancer Biology and Therapy (Deadline: 31 July 2026)
- Molecular Mechanisms and Immune Regulation in Prostate Cancer (Deadline: 31 July 2026)
- Targeted Cancer Therapeutics: Molecular Pathways and Precision Strategies (Deadline: 31 July 2026)
- Extracellular Vesicles as Drivers of Cancer Therapy Resistance: Mechanistic Insights and Emerging Therapeutic Strategies (Deadline: 31 July 2026)
- Epigenetic Mechanism in Gynecologic Oncology (Deadline: 31 July 2026)
- Molecular and Cellular Targets on Anticancer Research and Perspectives (Deadline: 20 August 2026)
- Urologic Cancers: Molecular Basis for Novel Therapeutic Approaches (Deadline: 20 August 2026)
- PD-L1 – PD1 Signaling Axis: From Mechanism to Therapeutics (Deadline: 20 August 2026)
- Novel Agents and Molecular Research in Multiple Myeloma (Deadline: 20 August 2026)
- Molecular Pathology and Treatment of Hepatocellular Carcinoma (Deadline: 20 August 2026)
- Oral Potentially Malignant Disorders and Oral Cancers: From Molecular Pathology to Therapeutic Approaches (Deadline: 20 August 2026)
- Research on the Key Role of Ubiquitination in Signaling and Cancer (Deadline: 20 August 2026)
- 25th Anniversary of IJMS: Updates and Advances in Molecular Oncology (Deadline: 20 August 2026)
- Synthetic Lethality Strikes: Outsmarting Cancer with Precision Medicine (Deadline: 20 August 2026)
- Challenges and Future Perspectives in Treatment for Lung Cancer: 2nd Edition (Deadline: 20 August 2026)
- Molecular Insight into Natural Nutraceuticals for Cancer Chemoprevention (Deadline: 20 August 2026)
- Predictive, Prognostic Biomarkers and Therapeutic Targets of Breast Cancer: Second Edition (Deadline: 20 August 2026)
- Breakthroughs in Anti-Cancer Agents Discovery (Deadline: 20 August 2026)
- Multiple Myeloma: Cancer Therapy and the Tumour Microenvironment (Deadline: 20 August 2026)
- Cell Proliferation and Differentiation in Cancer (Deadline: 20 August 2026)
- Focus on Chemoradiation Resistance: The Challenge of Cancer Therapy (Deadline: 20 August 2026)
- Recent Advances in Brain Tumor Research and Treatment (Deadline: 20 August 2026)
- Recent Advances in Brain Cancers: Second Edition (Deadline: 20 August 2026)
- Molecular Research and Insights into Anti-Cancer Vaccines (Deadline: 20 August 2026)
- Molecular Advances and Views in Triple-Negative Breast Cancer (Deadline: 20 August 2026)
- Recent Research on Natural Compounds in Cancer Treatment and Prevention (Deadline: 20 August 2026)
- Solid Tumors: From Molecular Mechanisms to Targeted Therapies (Deadline: 20 August 2026)
- Molecular Research on Oral Cancer (Deadline: 20 August 2026)
- MiRNA Regulation in the Early PME/TME: The Role of Non-Cancer Cells and the ECM in Solid Tumours (Deadline: 30 August 2026)
- Biomarkers and Early Detection Strategies of Ovarian Tumors: 2nd Edition (Deadline: 30 August 2026)
- Exploring the New Cancer Biomarkers: Progress and Prospects (Deadline: 31 August 2026)
- Novel Biomarkers and Emerging Therapeutic Targets for Breast and Gynecologic Cancers (Deadline: 31 August 2026)
- Advances in Basic and Translational Research in Colorectal Cancer (Deadline: 31 August 2026)
- Insights into Multiple Myeloma: Immune Microenvironment, Disease Mechanisms, and Therapeutic Innovations (Deadline: 31 August 2026)
- Functional Precision Medicine in Cancer: Organoid Models and Integrated Omics Profiling (Deadline: 31 August 2026)
- Contemporary Advancement in Personalized Medicine in Urological Cancers (Deadline: 31 August 2026)
- Interplay Between Cytoskeletal Dynamics and Cell Signaling in Cancer (Deadline: 31 August 2026)
- Recent Advancements in Cancer Immunotherapy (Deadline: 31 August 2026)
- Molecular Determinants of Response and Resistance in Cancer Immunotherapy (Deadline: 31 August 2026)
- Molecular Regulation of Cancer Stem Cells: Signaling Networks, Metabolism, and Therapeutic Targeting (Deadline: 31 August 2026)
- DNA Damage and Repair Mechanisms in Cancer Development (Deadline: 31 August 2026)
- Molecular Advances in Schwannomas: So-Called Benign Nervous System Tumors (Deadline: 31 August 2026)
- Multi-Omics Research in Oncology (Deadline: 31 August 2026)
- Recent Advances in Cancer Immunotherapy Research (Deadline: 31 August 2026)
- The Multiple Faces of Non-Small Cell Lung Cancer: Targeted Therapies and Recent Developments (Deadline: 20 September 2026)
- Towards Complex Molecular Cancer Therapies (Deadline: 20 September 2026)
- Molecular Mechanisms and Therapeutic Strategies of Colorectal Cancer (Deadline: 20 September 2026)
- Natural Compounds in Cancer: Targeting Immune Cells and Signalling Pathways (Deadline: 20 September 2026)
- Advanced Molecular Research in Brain Tumors (Deadline: 20 September 2026)
- Advances in Molecular Biology of Ovarian Cancer (Deadline: 20 September 2026)
- Modulating the Niche: Targeting the Tumor Microenvironment for Enhanced Therapy (Deadline: 20 September 2026)
- Melanoma: Molecular Mechanism and New Agents for Prevention and Therapy (Deadline: 20 September 2026)
- Recent Advances in New Biomarkers for Cancers (Deadline: 20 September 2026)
- Ongoing Anticancer Agents (Deadline: 20 September 2026)
- Current Research for Ovarian Cancer Biology and Therapeutics (Second Edition) (Deadline: 20 September 2026)
- Circulating Cell-Free Nucleic Acids and Cancers: 3rd Edition (Deadline: 20 September 2026)
- Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers, 3rd Edition (Deadline: 20 September 2026)
- New Advances in Cardio-Oncology: Mechanisms, Biomarkers, and Therapeutic Strategies (Deadline: 20 September 2026)
- Applications of Photodynamic Therapy in Cancer (Deadline: 20 September 2026)
- Pancreatic Ductal Adenocarcinoma: Unveiling Pathogenic Mechanisms and Pioneering Novel Therapeutic Strategies (Deadline: 20 September 2026)
- Molecular Diagnosis and Treatment of Oral Cancer (Deadline: 20 September 2026)
- Advancements in Prognostic and Predictive Biomarkers for Advanced Prostate Cancer (Deadline: 20 September 2026)
- Current Advances in Immuno-Oncology (Deadline: 20 September 2026)
- The Role of Long Non-Coding RNAs in Cancer Metastasis and Drug Resistance (Deadline: 20 September 2026)
- Application of Pulsed Electric Fields in Cancer Therapy (Deadline: 20 September 2026)
- Obesity and Cancer: Molecular, Cellular and Systemic Mechanisms Underlying Tumor Initiation, Progression and Prognosis (Deadline: 20 September 2026)
- Molecular Insight into Mesothelioma (Deadline: 25 September 2026)
- The Role of Tumor Microenvironment in Cancer Therapy (Deadline: 25 September 2026)
- Advances in Pathogenesis and Treatment of Skin Cancer (2nd Edition) (Deadline: 30 September 2026)
- Colorectal Cancer—Emerging Trends and Treatment Strategies (Deadline: 30 September 2026)
- Genetic and Molecular Markers in Prostate Cancer (Deadline: 30 September 2026)
- Neuroblastoma: Advances in Molecular Pathogenesis and Therapy (Deadline: 30 September 2026)
- State-of-the-Art Immunotherapy for Non-Small-Cell Lung Cancer (Deadline: 30 September 2026)
- Protein Dynamics in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities (Deadline: 30 September 2026)
- Biomarkers in Oncology (Deadline: 30 September 2026)
- Molecular Antimicrobial Resistance in Cancers (Deadline: 30 September 2026)
- Non-Coding RNAs as Key Players in Cancer Biology and Clinical Translation (Deadline: 30 September 2026)
- Recent Advances in Omics for Cancer Research (Deadline: 30 September 2026)
- Metabolomics in Cancer: From Biomarkers to Therapeutic Insights (Deadline: 30 September 2026)
- Extracellular Vesicles in Cancer and Tumor Microenvironment (Deadline: 30 September 2026)
- Molecular Mechanisms and Biology of Gynecological Cancers (Deadline: 30 September 2026)
- Mechanisms of Tumor–Immune System Interactions (Deadline: 30 September 2026)
- The Molecular Landscape of Gastroesophageal Cancer: Pathways to Novel Therapies (Deadline: 30 September 2026)
- Role of Bifunctional Antibodies in Human Cancer (Deadline: 30 September 2026)
- Treatment Approaches for EGFR-Mutated Lung Cancers (Deadline: 30 September 2026)
- Mechanisms of Carcinogenesis and Cancer Therapeutic Resistance (Deadline: 30 September 2026)
- Next-Generation Gene Therapy for Cancer: Oncolytic Viruses, Genome Editing, Targeted Delivery Systems and Preclinical Advances (Deadline: 30 September 2026)
- DNA Damage, DNA Repair, and Cancer, 3rd Edition (Deadline: 30 September 2026)
- Pancreatic Neuroendocrine Tumors: Current Evidence and Future Horizons (Deadline: 30 September 2026)
- Molecular Research on Melanoma (Deadline: 30 September 2026)
- Targeted Therapies and Chemoresistance in Gastrointestinal Cancers (Deadline: 30 September 2026)
- Biomechanics and Molecular Research on Glioblastoma: 2nd Edition (Deadline: 20 October 2026)
- Drugs Targeting Cancer Signaling Pathways: Dissecting Mechanisms to Unlock New Therapeutic Targets (Deadline: 20 October 2026)
- Fundamental and Translational Insights into Colorectal Cancer (Deadline: 20 October 2026)
- Exosomes in the Processes of Tumorigenesis, Cancer Progression, Metastasis, and Treatment (Deadline: 20 October 2026)
- Novel Immunotherapies for Reshaping the Tumor Immune Microenvironment (Deadline: 20 October 2026)
- Transforming in Cancer Therapy: Advances in Immunotherapy and Tyrosine Kinase Inhibitors (Deadline: 20 October 2026)
- Advances in Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer (Deadline: 20 October 2026)
- Skin Cancer: Molecular Drivers, Biomarkers, Non-Invasive Diagnostics and Therapeutic Strategies (Deadline: 20 October 2026)
- Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets—2nd Edition (Deadline: 20 October 2026)
- The Involvement of Stem Cells in Cancer (Deadline: 20 October 2026)
- Lung Cancer: Molecular Basis and Treatment Strategies (Deadline: 20 October 2026)
- Advanced Research in Cancer Pharmacotherapy (Deadline: 20 October 2026)
- Cancer Progression and Therapeutic Resistance Mechanisms (Deadline: 23 October 2026)
- Prostate Cancer: Molecular Mechanisms and Targeting (Deadline: 23 October 2026)
- Updates and Advances in the Field of Glioblastomas: Mechanisms, Microenvironment and Treatments (Deadline: 30 October 2026)
- Global Impact of Malignant Pleural Mesothelioma: Current Knowledge, Emerging Therapies and Future Perspectives (Deadline: 30 October 2026)
- Microenviromental Signalling in Tumorigenesis and Anti-Cancer Drugs Resistance (Deadline: 31 October 2026)
- Tumor Markers and Tumor Microenvironment (Deadline: 31 October 2026)
- Advances in Reprogramming of Mitochondrial Signalling and Metabolism in Cancers (Deadline: 31 October 2026)
- Molecular Mechanisms of Melanoma Resistance to Targeted Therapy (Deadline: 31 October 2026)
- Molecular Targeted Therapy and Epigenetic Advances in Cancer (Deadline: 31 October 2026)
- KRAS-Associated Cancer Signaling (Deadline: 31 October 2026)
- Emerging Targeted Therapies and Evolving Treatment Paradigms in Non-Small Cell Lung Cancer (Deadline: 31 October 2026)
- Molecular Targets for HPV-Related Head and Neck Cancer (Deadline: 31 October 2026)
- Molecular Insights into Cancer Biomarkers and Targeted Therapies in Solid Tumors (Deadline: 31 October 2026)
- Recent Advances in Therapeutic Targets for Musculoskeletal Tumors (Deadline: 31 October 2026)
- The State of the Art in Immuno-Oncology: What to Do with Glioblastoma? (Deadline: 31 October 2026)
- Neuroendocrine Tumors (NETs): New Molecular Insights (Deadline: 31 October 2026)
- Molecular Mechanisms of Resistance to Targeted Cancer Therapies (Deadline: 31 October 2026)
- Advances in Computational Research in Molecular Oncology: Tumor Initiation, Progression, and Treatment (Deadline: 31 October 2026)
- New Insights into Gastroesophageal Tumors (Deadline: 31 October 2026)
- Repurposed Anti-Cancer Drugs (Deadline: 31 October 2026)
- Signaling Pathways Dysregulation in Cancer: Advances and New Therapeutics Hopes: 2nd Edition (Deadline: 31 October 2026)
- Insights on the Efficacy and Safety of Cytotoxic Agents in Lung Cancer (Deadline: 31 October 2026)
- Protein S in Coagulation, Inflammation, and Cancer (Deadline: 31 October 2026)
- New Predictive Biomarkers for Ovarian Cancers (Deadline: 31 October 2026)
- Exploring Novel Molecular, Metabolic and Cellular Mechanisms for Developing New Therapeutic Targets Against Childhood Cancers, 2nd Edition (Deadline: 20 November 2026)
- Advanced Research on Cancer Stem Cells (Deadline: 20 November 2026)
- Advancing Precision Medicine in Urological Cancers: Integrating Multi-Omics and Optimizing Therapeutic Approaches (Deadline: 20 November 2026)
- Molecular Insights into Pediatric Cancer: Advances in Hematopoietic Stem Cell Research (Deadline: 20 November 2026)
- Molecular Pathogenesis and Treatment Approaches of Hematological Malignancies (Deadline: 20 November 2026)
- Molecular Diagnostics and Genomics of Tumors, 2nd Edition (Deadline: 20 November 2026)
- Human Meningioma: Recent Developments (Deadline: 20 November 2026)
- Molecular Mechanisms and Therapies of Colorectal Cancer: 5th Edition (Deadline: 20 November 2026)
- Targeting Receptor Tyrosine Kinases and Related Signalling Pathways in Cancer: Mechanisms, Resistance, and Therapeutic Advances (Deadline: 27 November 2026)
- Cellular Plasticity in Cancer: Mechanisms, Measurement and Therapeutic Opportunities (Deadline: 27 November 2026)
- Solid Tumours in Focus: Tissue Biomarkers and Spatial Technologies in Cancer Pathology (Deadline: 27 November 2026)
- Molecular Studies of Hematologic Malignancies (Deadline: 30 November 2026)
- Advances in Novel Therapeutic Strategies for Cancers (Deadline: 30 November 2026)
- Future Challenges and Innovation in Gynecological Oncology (Deadline: 30 November 2026)
- The Role of Transcription Factors in Cancer (Deadline: 30 November 2026)
- Bone Microenvironment and Bone Metastasis (Deadline: 30 November 2026)
- Recent Advances in Urological Cancer (Deadline: 30 November 2026)
- Molecular Studies in Gynecological Oncology: Advancing Diagnosis and Treatment (Deadline: 30 November 2026)
- Circulating Biomarkers for the Diagnosis of Cancer (Deadline: 30 November 2026)
- T Cell Malignancies: Translating Basic Research into Better Therapy (Deadline: 30 November 2026)
- Advances in the Molecular Pathogenesis of Gastrointestinal Malignancies with Implications for Diagnosis and Therapy (Deadline: 30 November 2026)
- Exploring Natural Products for Cancer (Deadline: 30 November 2026)
- Endometrial Cancer: From Molecular Mechanisms to Treatment (Deadline: 30 November 2026)
- Advances in the Reprogramming of Mitochondrial Signalling and Metabolism in Cancers (Deadline: 30 November 2026)
- Modern Synthetic Pathways for Anticancer Drug Discovery (Deadline: 30 November 2026)
- Viral Infections and Cancer: Recent Advances and Future Perspectives (2nd Edition) (Deadline: 30 November 2026)
- Precision Nutrition and Cancer: Molecular Insights into Cancer Prevention and Development (Deadline: 30 November 2026)
- Novel Diagnostic and Theragnostic Strategies in Brain Tumors (Deadline: 30 November 2026)
- Emerging Biological Markers and Molecular Targets in Bladder Cancer (Deadline: 30 November 2026)
- Molecular Research and Cellular Biology of Breast Cancer: 2nd Edition (Deadline: 30 November 2026)
- Design, Synthesis and Development of Anticancer Drugs Targeting the Tumor Microenvironment (Deadline: 30 November 2026)
- From Pathogenic Mechanisms to Therapy in Gynecological Diseases (Deadline: 30 November 2026)
- Advanced Research on Esophageal Cancer (Deadline: 30 November 2026)
- Translational Advances in Melanoma Molecular Research (Deadline: 30 November 2026)
- Next-Generation Sequencing Assays in Precision Oncology (Deadline: 30 November 2026)
- Deep Learning Biomarkers for Cancer Therapy (Deadline: 30 November 2026)
- Novel Therapeutic Targets in Cancers: 5th Edition (Deadline: 30 November 2026)
- Cancer Biomarkers: From Early Detection to Prognosis (Deadline: 30 November 2026)
- Molecular Pathogenesis and Targeted Therapies of Hematological Malignancies (Deadline: 30 November 2026)
- Molecular Biomarkers and Precision Medicine in Cancer (Deadline: 30 November 2026)
- Molecular Mechanisms of Bladder Cancer (Deadline: 1 December 2026)
- Immunotherapy Versus Immune Modulation of Leukemia (Deadline: 20 December 2026)
- Advances in Molecular Research on Cancer Treatments: Apoptosis, Autophagy, and Drug Selection (Deadline: 20 December 2026)
- Cancer Biology and Epigenetic Modifications (Deadline: 20 December 2026)
- Molecular Advances and Novel Biomarkers in Gastrointestinal Cancers (Deadline: 20 December 2026)
- Decoding the Pediatric Brain Tumor Microenvironment: A Molecular Perspective (Deadline: 25 December 2026)
- Identification of Predictive Molecular Markers for Cancer Progression, Response to Therapy, and Disease Outcome (Deadline: 25 December 2026)
- Gene Delivery in Cancer Therapy: Next-Generation Platforms and Translational Advances (Deadline: 25 December 2026)
- Recent Advances in Molecular Targets for Treatment and Drug Delivery in Tumors: 2nd Edition (Deadline: 25 December 2026)
- Liquid Biopsies in Oncology—3rd Edition (Deadline: 31 December 2026)
- Genomic-Defined Non-Small Lung Cancer (NSCLC) in the Real World: From Biology to Clinical Approaches (Deadline: 31 December 2026)
- Latest Research on Drug-Diagnostic Co-Development in Oncology (Deadline: 31 December 2026)
- Novel Therapeutic Strategies for Hepatocellular Carcinoma (Deadline: 31 December 2026)
- Discovering Natural Products for Cancer (Deadline: 31 December 2026)
- Research Progress on Cancer Biomarkers and Molecular Targets (Deadline: 31 December 2026)
- Sellar Region Tumors: New Insights in Their Pathogenesis, Diagnosis and Treatment (Deadline: 31 December 2026)
- Cancer-Driving Molecules: From Molecular Mechanisms to Novel Therapeutics (Deadline: 29 January 2027)
- Extracellular Vesicles in Tumor Growth and Progression (Deadline: 30 January 2027)
- DNA Damage and Repair Mechanisms in Cancer (Deadline: 31 January 2027)
- Molecular Therapeutic Strategies for Intrahepatic Cholangiocarcinoma (Deadline: 31 January 2027)
- Cancer, Chronic Disease and Health Equity: Translational Oncology in the Era of Multimorbidity and Systems Innovation (Deadline: 31 January 2027)
- Progress of Novel Biomarkers and Molecular Targets in Cancer (Deadline: 31 January 2027)
Topical Collections
Following topical collections within this section are currently open for submissions:
